Here, we harness the power of functional and molecular MRI to develop an image-guided paradigm to detect and measure changes in cardiac fibrosis in response to Chordin-like 1 (Chrdl1) gene therapy after MI. This evidence concerns the gene CHRDL1 and myocardial infarction.